Transcriptomic analysis of specific genes involved in immune activation, suppression, immune checkpoint receptors, and metabolic genes using the nCounter panel generated molecular evidence for tumor cell-induced downregulation of antitumor functions and for the beneficial effects of TRX1 enhancement. Here, TXN is linked to neoplasm.